Aranthan S. Jones II Net Worth & Insider Trades

Aranthan S. Jones II - Chief Corp. Affairs Officer, Vanda Pharmaceuticals Inc

As of September 17, 2021

What is Aranthan S. Jones II's Net Worth?

The current estimated net worth of Vanda Pharmaceuticals Inc's Chief Corp. Affairs Officer, Aranthan S. Jones II, is estimated to be about $2M . Aranthan S. Jones II owns about 81,980 units of Vanda Pharmaceuticals Inc common stock. In the last year at Vanda Pharmaceuticals Inc, Aranthan S. Jones II has sold an estimated value of $1.43M worth.

What is Aranthan S. Jones II's Past Insider Trading?

Aranthan S. Jones II's largest purchase order was 48,299 units , worth over $276.06K on February 26, 2021. Aranthan S. Jones II's largest sale order was 22,986 units , worth over $460.03K on February 26, 2021. In total, Aranthan S. Jones II has made about 8 transactions over a year of their time at Vanda Pharmaceuticals Inc. Aranthan S. Jones II usually trades in March, July and February, with the busiest year in 2021. The most recent transaction was a sale order of 16,824 units , worth over $277.39K on September 17, 2021.

Aranthan S. Jones II

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What was Aranthan S. Jones II's Salary in 2020?

As Chief Corp. Affairs Officer of Vanda Pharmaceuticals Inc, Aranthan S. Jones II has a total base salary of $406,104 . Aranthan S. Jones II received compensation valued at about $1,378,317 in 2020 after becoming Chief Corp. Affairs Officer. The vast majority of their compensation came in the form of stock awards of $339,600 , option awards of $397,915 , other earnings, plans or compensations of $201,021 , and other compensation of $33,677 .

What is Aranthan S. Jones II's' Mailing Address?

  • Mailing address is 2200 Pennsylvania Ave Nw Suite 300e Washington Dc DC 20037 DC

Vanda Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Mihael H. Polymeropoulos, M.D. 2020 $746,235 - $679,200 $795,830 $656,687 $35,468 $2,913,420
Mihael H. Polymeropoulos, M.D. 2019 $721,000 - $1,237,200 $1,610,154 $675,000 $34,783 $4,278,137
Mihael H. Polymeropoulos, M.D. 2018 $700,000 - $1,131,000 $1,456,406 $700,000 $37,322 $4,024,728
James P. Kelly 2020 $124,057 - - - - $16,217 $140,274
James P. Kelly 2019 $493,370 - $618,600 $805,077 $288,622 $42,741 $2,248,410
James P. Kelly 2018 $479,000 - $754,000 $832,232 $299,375 $36,778 $2,401,385
Kevin Moran 2020 $324,693 - $331,101 $427,779 $200,000 $36,126 $1,319,699
Joakim Wijkstrom 2020 $506,422 - $339,600 $397,915 $250,679 $29,269 $1,523,885
Aranthan "AJ" Jones II 2020 $406,104 - $339,600 $397,915 $201,021 $33,677 $1,378,317
Timothy Williams 2020 $400,000 - $339,600 $397,915 $200,000 $41,546 $1,379,061
Timothy Williams 2019 $379,315 - $618,600 $805,077 $177,520 $42,342 $2,022,854
Timothy Williams 2018 $144,886 $40,000 $643,500 $1,086,894 $71,918 $15,658 $2,002,856
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1347178/000134717821000008/vnda-20210422xdef14a.htm

What are Vanda Pharmaceuticals Inc's Past Insider Trades?

Vanda Pharmaceuticals Inc's most recent insider trade came on March 6, 2023 by Timothy Williams who sold 16,738 units worth $104.57K . In the last 17 years, insiders at Vanda Pharmaceuticals Inc have sold an estimated value of $297.86M and bought an estimated value of $28.74M worth of shares. Insider trading is most common in June, with the busiest year in 2006. The most active traders at the company are Mihael Polymeropoulos, President and CEO,  James P. Kelly, EVP & Chief Financial Officer,  and Richard W Dugan, Director .

Vanda Pharmaceuticals Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...